Queensland Life Sciences Industry Report 2012 (PDF, 3.5MB)

More documents

Recommendations

Info

Queensland Life Sciences Industry Report 2012 18 2.14 Comparison of Industry Wide Estimates from 2007 to 2011 The figures presented in the following three Tables include estimates only for the Queensland Industry in 2007, 2009 and 2011, based on a statistical extrapolation of data from a sample of the industry population (i.e. data from those who responded to the survey conducted in each respective year). The sample of organisations that respond will be different each year and so direct comparisons must be made in knowledge of the potential for extreme variability in the data. In 2007, the analysis of the QLS Industry involved two separate surveys: for Biotechnology and for Therapeutic Medicines and Devices (TMD). However, these two sectors overlap in terms of their definition, and a number of organisations could have fallen into either sector. For the 2009 and 2011 surveys, the Biotechnology and TMD groups were merged into a more broadly defined QLS Industry. To allow a trend analysis of key parameters for TABLE 4: Queensland Life Sciences Industry: whole of industry estimates — Trends a 10 Australian Bureau of Statistics 6202.0 - Labour Force Australia the Biotechnology and TMD sectors since 2007, the data from the 2009 and the current survey were also analysed according to this division. Of the 301 organisations in the industry, 133 (44%) were deemed to be operating in Biotechnology, and 168 (56%) in TMD. A similar statistical methodology was employed for estimates from the 2011 and 2009 survey data. In some cases, the 2007 Queensland Biotechnology and TMD survey results were reanalysed using the methodology applied to the 2009 and 2011 survey data. Please note that income data for the TMD analysis in 2007 was collected as an income range and not a specific figure, as was the case in subsequent surveys. Queensland-wide employment estimates decreased by 28.5% from the 2009 estimates (Table 4). The majority of employees were lost from companies (down by 40%), with estimates for research organisations being similar in 2009 and 2011 (down by 3%). 2007 Survey b 2009 Survey 2011 Survey Difference 2009-2011 CAGR 2007-2011 Employment (FTEs) All Industry 15,569 19,731 14,106 -28.5% -2.4% Companies N/A 13,442 8008 -40.4% Research Organisations N/A 6289 6098 -3.1% c Qld Labour Force Growth10 Total Income ($m) 1.9% All Industry $3130 $4943 $4361 -11.8% 8.7% Companies N/A $3844 $3275 -14.8% Research Organisations N/A $1099 $1086 -1.2% c Expenditure ($m) Total Expenditure ($m) All Industry N/A $4682 $4626 -1.2% c Companies N/A $4177 $3271 -21.7% Research Organisations Wage and Salary Expenditure ($m) N/A $504 $1355 169.0% All Industry $789 $1078 $2141 98.6% 28.4% Companies N/A $929 $1323 42.4% Research Organisations R&D Expenditure ($m) N/A $149 $818 449.0% All Industry N/A $803 $657 -18.2% Companies N/A $417 $245 -43.1% Research Organisations N/A $386 $412 6.7% c Capital Expenditure ($m) All Industry $704 $253 $692 174% -0.4% Companies N/A $181 $514 184% Research Organisations N/A $72 $178 147% a Numbers may appear inconsistent due to rounding N/A = not applicable b Combined estimates from previous Biotechnology and TMD Surveys c These changes fall within the confidence interval
It was estimated that $2141 million was spent on salaries by the Queensland industry in 2011 including $818 million by research organisations and $1323 million by companies (Table 4). This was almost double the amount estimated for 2009 due to a greater than four-fold increase for ROs and a 40% increase for companies. The estimated income across the entire Industry was $4.36 billion in 2011 (Table 4). This is 11.8% lower than the $4.94 billion estimate in 2009 but 39.3% higher than the estimate in 2007 (combined total from the Queensland Biotechnology and TMD Surveys). The income decline in 2011 was largely attributed to companies, with estimates down by 14.8% compared to a 1.2% decline for research organisations. Based on these estimates, the CAGR for income was 8.7% between 2007 and 2011. The estimated expenditure across the entire QLS Industry was $4.63 billion in 2011 (Table 4), with just over 70% of that attributed to the private sector. 2.15 Estimates for the Biotechnology Sector — 2007 to 2011 TABLE 5: Queensland Biotechnology sector: whole of industry estimates 2007 — 2011 For companies, employment estimates were down significantly in 2011 (by 40.4%) compared to 2009. Total expenditure was down by 21.7% most likely due to a significant (43.1%) fall in R&D expenditure. Expenditure on wages was estimated to have increased by 42%, suggesting that work previously undertaken in-house may have been outsourced, and/or that some staff had were re-engaged as sub-contractors rather than employees. Total income was down by a comparably small 14.8% (just outside the margin of error), in the face of a much greater fall in estimated expenditure. Companies may be adopting a more conservative approach, seeking to retain more of the earnings on the expectation of a continued negative economic climate. For research organisations, employment and income were down marginally and R&D expenditure was up slightly — all of these figures were within the statistical margin of error. Expenditure estimates were substantially higher possibly reflecting the draw down on funds awarded 2-3 years previous. 2007 Survey* 2009 Survey 2011 Survey a Difference 2009-2011 CAGR 2007-2011 Biotechnology Employment (FTEs) All Biotechnology Sector 7630 9929 8021 -19.3% 1.3% Companies 1840 3760 2150 -42.9% 4.0% Research Organisations Biotechnology Income ($m) 5790 6169 5871 -4.9% 0.4% All Biotechnology Sector $896 $2185 $1665 -23.8% 16.8% Companies $395 $1093 $597 -45.4% 10.9% Research Organisations Biotechnology Expenditure ($m) Total Expenditure ($m) $501 $1092 $1068 -2.2% 20.9% All Biotechnology Sector ND $1710 $1775 3.8% Companies ND $1254 $437 -65.2% Research Organisations Wage and Salary Expenditure ($m) ND $456 $1338 193.0% All Biotechnology Sector $502 $384 $1085 183% 21.3% Companies $348 $244 $279 14.3% -5.4% Research Organisations R&D Expenditure ($m) $154 $140 $806 475% 51.3% All Biotechnology Sector $641 $550 $510 -7.3% -5.6% Companies $230 $170 $98 -42.4% -19.2% Research Organisations Capital Expenditure ($m) $411 $380 $412 8.4% 0.1% All Biotechnology Sector $469 $172 $217 26.2% -17.5% Companies $41 $103 $43 -58.3% -1.2% Research Organisations * Queensland Biotechnology Survey 2007; $428 $69 $174 152% -20.2% ND = not determined a for bias corrected 95% confidence intervals for each estimate please see Chapter 13 Numbers may appear inconsistent due to rounding. An estimated 8021 FTEs were employed in the Biotechnology sector. Estimates for the private biotechnology sector suggest major falls in employment, income and expenditure. Public sector research organisations in biotechnology showed marginal falls in estimates for employment and income with marked increases in expenditure, particularly that on wages. 19
Page 1 and 2: Queensland Life Sciences Industry R
Page 3 and 4: Since VenturePro was established in
Page 5 and 6: Strata were defined by industry (TM
Page 7 and 8: TABLE OF CONTENTS IMPORTANT NOTICE
Page 9 and 10: Queensland’s listed Life Sciences
Page 20: Queensland Life Sciences Industry R
Page 33 and 34: 5.2 Total Estimated Life Sciences I
Page 35 and 36: TABLE 22: IBISWorld industry statis
Page 37 and 38: TABLE 28: Wage and Salary Expenditu
Page 39 and 40: Research organisations reported tha
Page 65 and 66: 10.2 Finance 10.2.1 Debt and Equity
Page 67 and 68: Figure 33: Number of patent applica
Page 69 and 70:
By Anne-Marie Birkill, Partner at O
Page 71 and 72:
11.1.2 Contract Manufacturing Half
Page 73 and 74:
Figure 43: Importance of Queensland
Page 76 and 77:
Queensland Life Sciences Industry R
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90:
show all

Queensland Life Sciences Industry Report 2012 (PDF, 3.5MB)

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?